208 related articles for article (PubMed ID: 23577124)
1. Whole genome and transcriptome sequencing of a B3 thymoma.
Petrini I; Rajan A; Pham T; Voeller D; Davis S; Gao J; Wang Y; Giaccone G
PLoS One; 2013; 8(4):e60572. PubMed ID: 23577124
[TBL] [Abstract][Full Text] [Related]
2. Recurrent genetic aberrations in thymoma and thymic carcinoma.
Zettl A; Ströbel P; Wagner K; Katzenberger T; Ott G; Rosenwald A; Peters K; Krein A; Semik M; Müller-Hermelink HK; Marx A
Am J Pathol; 2000 Jul; 157(1):257-66. PubMed ID: 10880395
[TBL] [Abstract][Full Text] [Related]
3. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas.
Inoue M; Starostik P; Zettl A; Ströbel P; Schwarz S; Scaravilli F; Henry K; Willcox N; Müller-Hermelink HK; Marx A
Cancer Res; 2003 Jul; 63(13):3708-15. PubMed ID: 12839963
[TBL] [Abstract][Full Text] [Related]
4. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
[TBL] [Abstract][Full Text] [Related]
6. Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.
Lee Y; Park S; Lee SH; Lee H
BMC Cancer; 2017 May; 17(1):330. PubMed ID: 28506304
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of thymoma.
Badve S; Goswami C; Gökmen-Polar Y; Nelson RP; Henley J; Miller N; Zaheer NA; Sledge GW; Li L; Kesler KA; Loehrer PJ
PLoS One; 2012; 7(8):e42669. PubMed ID: 22912720
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
[TBL] [Abstract][Full Text] [Related]
9. Prediction of thymoma histology and stage by radiographic criteria.
Yanagawa M; Tomiyama N
Thorac Surg Clin; 2011 Feb; 21(1):1-12, v. PubMed ID: 21070982
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.
Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H
Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456
[TBL] [Abstract][Full Text] [Related]
11. Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis.
Moreira AL; Won HH; McMillan R; Huang J; Riely GJ; Ladanyi M; Berger MF
J Thorac Oncol; 2015 Feb; 10(2):373-80. PubMed ID: 25299233
[TBL] [Abstract][Full Text] [Related]
12. Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma.
Karube Y; Kobayashi S; Maeda S; Sado T; Ishihama H; Chida M
J Cardiothorac Surg; 2016 May; 11(1):85. PubMed ID: 27387303
[TBL] [Abstract][Full Text] [Related]
13. The genomic and epigenomic landscape in thymic carcinoma.
Saito M; Fujiwara Y; Asao T; Honda T; Shimada Y; Kanai Y; Tsuta K; Kono K; Watanabe S; Ohe Y; Kohno T
Carcinogenesis; 2017 Oct; 38(11):1084-1091. PubMed ID: 28968686
[TBL] [Abstract][Full Text] [Related]
14. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
15. Associations between computed tomography features of thymomas and their pathological classification.
Ozawa Y; Hara M; Shimohira M; Sakurai K; Nakagawa M; Shibamoto Y
Acta Radiol; 2016 Nov; 57(11):1318-1325. PubMed ID: 26089525
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis.
Kostic Peric J; Cirkovic A; Srzentic Drazilov S; Samardzic N; Skodric Trifunovic V; Jovanovic D; Pavlovic S
Radiol Oncol; 2023 Mar; 57(1):12-19. PubMed ID: 36942904
[TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.
Tateyama H; Sugiura H; Yamatani C; Yano M
Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
20. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
